Page last updated: 2024-08-23

paroxetine and thrombin receptor peptide sfllrnp

paroxetine has been researched along with thrombin receptor peptide sfllrnp in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andonovski, T; Dukic, A; Jilma, B; Kotzailias, N; Serebruany, VL1

Trials

1 trial(s) available for paroxetine and thrombin receptor peptide sfllrnp

ArticleYear
Antiplatelet activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male smokers: a randomized, placebo-controlled, double-blind trial.
    Journal of clinical pharmacology, 2006, Volume: 46, Issue:4

    Topics: Adult; Aspirin; Collagen; Cross-Over Studies; Double-Blind Method; Drug Synergism; Epinephrine; Flow Cytometry; Humans; In Vitro Techniques; Male; P-Selectin; Paroxetine; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Selective Serotonin Reuptake Inhibitors; Smoking

2006